HR and breast cancer: HR+/HER2- is the most common subtype of BC, which has the best prognosis; HR+ refers to the presence of estrogen and/or progesterone receptors in the tumor cells, and HER2- refers to the presence of a high level of a protein called HER2/neu [23].